Genpharmasec Share Price
Small Cap | Service | BSE: 531592
₹2.25 
-0.04 (-1.75 %)
Last Updated: 11 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 2.36
High (₹) 2.37
Low (₹) 2.21
Prev. Close (₹) 2.29
Volume 10,75,420
VWAP (₹) 2.20
ROCE (%) 0.96
Industry P/E 40.30
TTM P/E --
P/B Ratio 1.92
Market Cap (₹) Cr.124.59
Dividend Yield (%)--
EPS (₹) -0.01
ROE-0.85%
Sales Growth (%) --
Profit Growth (%)--
Day Range
2.372.37
52 Week Range
1.924.72
Historical Returns
Returns (6M)
-0.88 %
Returns (1Y)
-50.44 %
Returns (3Y)
-43.04 %
Returns (5Y)
-73.44 %
Returns (6M)
-0.88 %
Returns (1Y)
-50.44 %
Returns (3Y)
-43.04 %
Returns (5Y)
-73.44 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 36.00
MFI 11.06
ATR 0.19
Commodity Channel Index -107.74
ROC125 2.28
ROC21 -34.31
Williams %R -88.04
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2.31 | 2.39 | 2.48 | 2.22 | 2.14 | 2.05 | 1.97 |
| Week Ago | 2.45 | 2.49 | 2.57 | 2.37 | 2.33 | 2.25 | 2.21 |
| Month Ago | 3.33 | 3.44 | 3.63 | 3.14 | 3.03 | 2.84 | 2.73 |
EMA & SMA
2.25
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 2.40
9 Day 2.37
10 Day 2.40
12 Day 2.57
14 Day 2.59
20 Day 2.71
26 Day 2.83
50 Day 3.06
100 Day 3.05
200 Day 2.71
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| DIVYA DEVEN PATHAK | bulk | Sell | 30 Dec, 2024 | ₹2.95 | 35,00,000 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 04 Sept, 2024 | ₹3.31 | 28,57,581 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 03 Sept, 2024 | ₹3.27 | 9,31,149 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 03 Sept, 2024 | ₹3.18 | 30,57,693 | BSE |
| ISHAAN TRADEFIN LLP | bulk | Sell | 30 Aug, 2024 | ₹3.87 | 45,00,000 | BSE |
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 30 Aug, 2024 | ₹3.78 | 34,00,003 | BSE |
| ISHAAN TRADEFIN LLP | bulk | Buy | 30 Aug, 2024 | ₹3.71 | 45,00,000 | BSE |
| STALLION WEALTH MANAGEMENT LLP | bulk | Sell | 27 Aug, 2024 | ₹3.31 | 13,50,000 | BSE |
| ISHAAN TRADEFIN LLP | bulk | Sell | 27 Aug, 2024 | ₹3.36 | 40,00,000 | BSE |
| STALLION WEALTH MANAGEMENT LLP | bulk | Buy | 27 Aug, 2024 | ₹3.36 | 60,50,000 | BSE |
| YOGESH KUMAR GAWANDE | block | Sell | 30 Jul, 2021 | ₹11.27 | 16,80,526 | BSE |
| YOGESH KUMAR GAWANDE | block | Buy | 30 Jul, 2021 | ₹11.12 | 16,80,526 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 06 May, 2020 | Rajesh Sadhwani | Disposal | ₹1.00 | 40,00,000 | BSE |
| 06 May, 2020 | Rajesh Sadhwani | Acquisition | ₹1.00 | 40,00,000 | BSE |
| 06 May, 2020 | Sneha Sadhwani | Disposal | ₹1.00 | 2,00,00,000 | BSE |
| 06 May, 2020 | Sneha Sadhwani | Acquisition | ₹1.00 | 2,00,00,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 05 Jun, 2023 | Rights issue of equity shares of Re. 1/- in the ratio of 1:1 @ premium of Re. 0.75/-. | 09 Jan, 2024 | 09 Jan, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 03 Feb, 2025 | BSE India | Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter and nine months ended 31st December, 2024; 2. To consider any other business with the permission of a Chairman. |
| 10 Dec, 2024 | BSE India | Press Release regarding recent agreement with Amneal Healthcare Private Limited. |
| 12 Nov, 2024 | BSE India | Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 30th September, 2024. |
| 12 Nov, 2024 | BSE India | Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2024. |
| 12 Nov, 2024 | BSE India | Outcome of the Meeting of Board of Directors held on Tuesday, November 12, 2024. |
| 05 Nov, 2024 | BSE India | Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve 1. To consider and approve Un-audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter and half year ended September 30, 2024;\r\n2. To consider any other business with the permission of a Chairman.\r\n |
| 08 Oct, 2024 | BSE India | Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulation, 2018 for the quarter ended September 30, 2024. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 04 Feb, 2025 | 10 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 12 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 13 Aug, 2024 |
| A.G.M. | -- | 26 Jun, 2024 | 27 Jun, 2024 |
| Audited Results | -- | 15 May, 2024 | 24 May, 2024 |
| Others | inter alia, to consider : 1. To consider and take on record the resignation of Mr. Ulhas Deosthale from the post of Whole-Time Director; | 24 Mar, 2024 | 27 Mar, 2024 |
| Independent Director Meeting | -- | 24 Mar, 2024 | 26 Mar, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 12 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 11 Aug, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Feb, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Genpharmasec
Genpharmasec is a Public Limited Listed company incorporated on 16/11/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1992PLC323914 and registration number is 018572. Currently company belongs to the Industry of Trading & Distributors. Company’s Total Operating Revenue is Rs. 30.41 Cr. and Equity Capital is Rs. 55.37 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1992
Managing Director
-- --
NSE Symbol
--
Genpharmasec Management
| Name | Designation |
|---|---|
| Mr. Sohan Chaturvedi | WholeTime Director & CFO |
| Mrs. Sneha Sadhwani | Non Exe.Non Ind.Director |
| Mr. Rajesh Mirchumal Sadhwani | Non Exe.Non Ind.Director |
| Mr. Siddhesh Shende | Independent Director |
| Mr. Mayur Bhatt | Independent Director |
| Mr. Sachin Prakash Aphandkar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Adani Enter | ₹2,78,151.78 | ₹2,321.75  ₹2,290.80(1.35%) | ₹2,030.000 - ₹3,743.000 |
| MMTC | ₹10,980.00 | ₹63.80  ₹65.90(-3.19%) | ₹58.830 - ₹131.880 |
| Shree Global | ₹5,975.18 | ₹48.38 ₹50.39(-3.99%) | ₹27.300 - ₹54.600 |
| MSTC Ltd | ₹4,742.14 | ₹583.50 ₹560.55(4.09%) | ₹558.250 - ₹1,165.000 |
| KansalFibres | ₹1,766.92 | ₹7.37 ₹7.02(4.99%) | ₹3.595 - ₹44.660 |
FAQs on Genpharmasec
What is the share price of Genpharmasec?
The share price of Genpharmasec on 11 Feb, 2025 is ₹ 2.25.
What is 52W high and 52W low share price of Genpharmasec?
The highest and lowest 52W share prices of Genpharmasec are ₹ 7.310 and ₹ 1.920
What is the market cap of Genpharmasec?
The market capitalization of Genpharmasec as of 11 Feb, 2025 is ₹ 124.59 Crores
What is the P/E ratio of Genpharmasec?
The current P/E ratio of Genpharmasec as of 11 Feb, 2025 is 40.30
What is the PB ratio of Genpharmasec?
The PB ratio of Genpharmasec as of 11 Feb, 2025 is 1.92
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)